| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 60.1K | $64K | $1.06 | Jul 1, 2025 | Direct |
| PMV Pharmaceuticals, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 265K | Mar 3, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals, Inc. | Jul 1, 2025 | 1 | -$30.1K | 4 | Jul 3, 2025 | Chief Financial Officer |
| PMVP | PMV Pharmaceuticals, Inc. | Mar 3, 2025 | 1 | $0 | 4 | Mar 5, 2025 | Chief Financial Officer |
| PMVP | PMV Pharmaceuticals, Inc. | Sep 11, 2024 | 1 | -$4.35K | 4 | Sep 12, 2024 | Chief Financial Officer |
| PMVP | PMV Pharmaceuticals, Inc. | Aug 13, 2024 | 5 | $0 | 4 | Oct 3, 2024 | Chief Financial Officer |
| PMVP | PMV Pharmaceuticals, Inc. | Jan 18, 2024 | 2 | $0 | 4 | Jan 22, 2024 | Chief Financial Officer |
| PMVP | PMV Pharmaceuticals, Inc. | Jan 5, 2024 | 0 | $0 | 3 | Jan 11, 2024 | Chief Financial Officer |